MARKET

ALIM

ALIM

Alimera Sciences
NASDAQ
3.600
0.000
0.00%
Opening 12:08 12/07 EST
OPEN
3.590
PREV CLOSE
3.600
HIGH
3.770
LOW
3.570
VOLUME
50.13K
TURNOVER
0
52 WEEK HIGH
3.900
52 WEEK LOW
1.300
MARKET CAP
188.70M
P/E (TTM)
-1.3686
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ALIM last week (1127-1201)?
Weekly Report · 3d ago
Alimera Sciences: Statement of changes in beneficial ownership of securities
Press release · 11/29 04:02
Weekly Report: what happened at ALIM last week (1120-1124)?
Weekly Report · 11/27 11:39
Weekly Report: what happened at ALIM last week (1113-1117)?
Weekly Report · 11/20 11:36
Weekly Report: what happened at ALIM last week (1106-1110)?
Weekly Report · 11/13 11:28
Alimera Sciences: Initial statement of beneficial ownership of securities
Press release · 11/09 01:34
Alimera Sciences: Statement of changes in beneficial ownership of securities
Press release · 11/09 01:34
Alimera Sciences: Current report
Press release · 11/08 22:46
More
About ALIM
Alimera Sciences, Inc. is a commercial-stage global pharmaceutical company. The Company is engaged in developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the United States for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant that enables patients to maintain vision longer, and importantly, with fewer injections. ILUVIEN is an intravitreal implant that treats patients by delivering a continuous micro dose of the corticosteroid fluocinolone acetonide (FAc) in the eye, for up to 36 months. ILUVIEN is inserted into the back of the patient's eye in a non-surgical procedure employing a device with a 25-gauge needle, which allows for a self-sealing wound. DME is also treated by Laser photocoagulation, a retinal procedure in which a laser is used to apply a burn, or a pattern of burns, to cauterize leaky blood vessels to reduce edema.

Webull offers Alimera Sciences Inc stock information, including NASDAQ: ALIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALIM stock methods without spending real money on the virtual paper trading platform.